Eusol Biotech Co (ROCO:6652) Marketable Securities : NT$95.51 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Eusol Biotech Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Eusol Biotech Co's Marketable Securities for the quarter that ended in Dec. 2024 was NT$95.51 Mil.

Eusol Biotech Co's annual Marketable Securities declined from Dec. 2022 (NT$250.60 Mil) to Dec. 2023 (NT$165.60 Mil) and declined from Dec. 2023 (NT$165.60 Mil) to Dec. 2024 (NT$95.51 Mil).

Eusol Biotech Co Marketable Securities Historical Data

The historical data trend for Eusol Biotech Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eusol Biotech Co Marketable Securities Chart

Eusol Biotech Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

30.00

250.60

165.60

95.51

Eusol Biotech Co Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Marketable Securities	Get a 7-Day Free Trial													250.60	244.60	165.60	147.60	95.51

Eusol Biotech Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Eusol Biotech Co (ROCO:6652) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Eusol Biotech Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Eusol Biotech Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Eusol Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eusol Biotech Co Ltd (ROCO:6652) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.135, Section 3, Minsheng East Road, 6th Floor, Songshan District, Taipei, TWN, 10546

Website

https://www.eusol.com.tw

Eusol Biotech Co Ltd is a Taiwan based company that invests in developing new drugs to fulfill unmet medical needs. Its pipeline products include ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) with 135 amino acids; and SM-1, a 3-in-1 capsule containing 3 commercial drugs with the sedative effect.

Eusol Biotech Co Headlines

No Headlines